Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$531K Sell
1,465
-216
-13% -$73.9K 0.14% 111
2026
Q1
$591K Sell
1,681
-525
-24% -$187K 0.18% 83
2025
Q4
$722K Buy
+2,206
New +$700K 0.24% 56

Other funds holding AMGN

Wellington Group's AMGN Position: Q2 2026 in Review

Wellington Group reduced its Amgen (AMGN) stake by 13% in Q2 2026, selling an estimated $73.9K and leaving 1,465 shares worth $531K. The position accounts for 0.14% of the portfolio, ranked #111.

Wellington Group first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $722K in Q4 2025. 3,146 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Wellington Group held 1,465 shares of Amgen worth $531K as of Q2 2026.
  • Wellington Group sold 216 Amgen shares in Q2 2026, an estimated $73.9K.
  • Amgen made up 0.14% of Wellington Group's portfolio in Q2 2026, its #111 holding.
  • Wellington Group first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
  • Wellington Group's Amgen position peaked at $722K in Q4 2025.
  • 3,146 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Wellington Group's 13F filing for Q2 2026, filed 14 Aug 2026.